{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:50:23Z","timestamp":1761490223734},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.rbmo.2017.02.012","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T19:38:35Z","timestamp":1488483515000},"page":"534-540","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ovarian response to 150\u2009\u00b5g corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study"],"prefix":"10.1016","volume":"34","author":[{"given":"Tamara","family":"Lerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Depenbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Askan","family":"Schultze-Mosgau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soeren","family":"von Otte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Scheinhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inke","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Kamischke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Macek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Schwennicke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Segerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Griesinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2017.02.012_bib0010","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0015","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/humrep\/deu090","article-title":"Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol","volume":"29","author":"Broekmans","year":"2014","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0020","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0025","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.rbmo.2010.03.019","article-title":"Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women","volume":"21","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0030","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarianstimulation using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0035","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/humupd\/dmn065","article-title":"Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency","volume":"15","author":"Fauser","year":"2009","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0040","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/humrep\/deu050","article-title":"Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay","volume":"29","author":"Han","year":"2014","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0045","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jim.2010.08.011","article-title":"Development of a second generation anti-M\u00fcllerian hormone (AMH) ELISA","volume":"31","author":"Kumar","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0050","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-M\u00fcllerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0055","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.fertnstert.2014.12.114","article-title":"Comparison of antim\u00fcllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials","volume":"103","author":"Nelson","year":"2015","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0060","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.fertnstert.2015.06.024","article-title":"Two new automated, compared with two enzyme-linked immunosorbent, antim\u00fcllerian hormone assays","volume":"104","author":"Nelson","year":"2015","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0065","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/humrep\/der163","article-title":"Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity","volume":"26","author":"Norman","year":"2011","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0070","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12958-015-0113-1","article-title":"Predictive factors for ovarian response in a corifollitropin alfa\/GnRH antagonist protocol for controlled ovarian stimulation in IVF\/ICSI cycles","volume":"31","author":"Oehninger","year":"2015","journal-title":"Reprod. Biol. Endocrinol"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0075","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.fertnstert.2013.04.029","article-title":"Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization\/intracytoplasmic sperm injection","volume":"100","author":"Polyzos","year":"2013","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2017.02.012_bib0080","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1093\/humrep\/dev127","article-title":"Performance of the two new fully automated anti-M\u00fcllerian hormone immunoassays compared with the clinical standard assay","volume":"30","author":"van Helden","year":"2015","journal-title":"Hum. Reprod"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648317300925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648317300925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T22:23:23Z","timestamp":1536013403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648317300925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1472648317300925"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2017.02.012","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian response to 150\u2009\u00b5g corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2017.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.","name":"copyright","label":"Copyright"}]}}